Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
Chemoprevention with Folic Acid
This study is currently recruiting patients.
Sponsored by: | Department of Veterans Affairs |
---|---|
Information provided by: | Department of Veterans Affairs |
Purpose
Colorectal neoplasia is the second most common cancer in the United States and other Western countries with about 140,000 newly diagnosed cases per year in the United States with a mortality rate of about 40%. The identification of a specific natural or synthetic compound with the ability to reverse or suppress the process of colon carcinogenesis would have profound implication in the development of colorectal adenomas and their subsequent transformation to colon cancer. Furthermore, the establishment of a correlative relationship between biomarkers of cell proliferation, differentiation, apoptosis and adenoma recurrence would provide pivotal data required to elucidate cell signaling mechanisms in future colon cancer chemoprevention trials.
Condition | Treatment or Intervention | Phase |
---|---|---|
Colon Cancer Adenoma Colonic Polyps |
Drug: Folic Acid |
Phase II |
MedlinePlus related topics: Cancer; Cancer Alternative Therapy; Colonic Polyps; Colorectal Cancer
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Efficacy Study
Official Title: 3389 Colorectal Adenoma: Chemoprevention with Folic Acid
Study start: October 1998;
Study completion: September 2003
Eligibility
Ages Eligible for Study: 18 Years - 80 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Location and Contact Information
More Information
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |